Genetic and Functional Analysis of Aplasia Cutis Congenital (ACC)
Part of paid clinical trials in Farmington, Connecticut.
- Sponsor
- UConn Health
- Study ID
- NCT01630421
- Status
- Recruiting
Conditions
- Aplasia Cutis Congenita
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this research study is to identify genes and regulatory elements on chromosomes that cause ACC. The investigators also study tissue samples from patients to learn about the processes that lead to this disorder.
Key Dates
- Start date
- Apr 30, 2009
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 600 participants (estimated)
Arms
- Arm: affected, unaffectedIndividuals with diagnosed ACC
Primary Outcome Measure
Identification of genetic elements [ Time Frame: at time of identification ]
Central Contacts
- Ernst J Reichenberger, PhD860-679-2062
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Connecticut Health Center | Farmington | Connecticut | 06030 |
Find similar trials in Farmington, CT
By research site